FindTrial
Sign In

Effect of vitamin B12 on hospitalized covid-19 patients.

Determining the effects of vitamin B12 on clinical outcome and complications of hospitalized covid-19 patients.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210515051304N1
Enrollment
20
Registered
2021-11-18
Start date
2021-10-04
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid-19. COVID19, virus identified

Interventions

Intervention 1: Intervention group: B-12 vitamin 1000mg/daily, 7 days, oral. Intervention 2: Control group: Vitamin B-12 placebo with the same volume, frequency, number of days and the same manufactu

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: consent age 18-75 years covid-19 patients hospitalized

Exclusion criteria

Exclusion criteria: nodding ventilator acute/chronic renal insufficiency liver insufficiency taking vitamin b12 in the past 3 months

Design outcomes

Primary

MeasureTime frame
Vitamin B12 blood level. Timepoint: before study, first 24 hours, day 7. Method of measurement: Blood sampling.;Mortality. Timepoint: at the end of hospitalization. Method of measurement: observation.;Need for mechanical ventilation. Timepoint: at the end of hospitalization. Method of measurement: file.;Spo2. Timepoint: daily. Method of measurement: pulse oximeter.;Vit-d blood level. Timepoint: day 1. Method of measurement: lab test.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Faraji

Tehran University of Medical Sciences

nedafaraji1368@gmail.com+98 21 5565 8500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026